Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Abera Bioscience AB logo — A vaccine plattform company

Abera Bioscience AB

A vaccine plattform company

Founded 2012 Sweden Sweden 11 employees Biotechnology, Health Care

General Information

Company Name Abera Bioscience AB
Founded Year 2012
Location Sweden Sweden
Employees 11
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Abera Bioscience AB. To contact Abera Bioscience AB, visit aberabio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Abera Bioscience AB

Abera Bioscience AB is a Swedish biotech company headquartered in Stockholm, dedicated to developing novel vaccines and vaccine development technologies. The Company's expertise in Biochemistry and Molecular Microbiology has led to the generation of a patented platform technology for the development of novel vaccines. Their unique approach involves bringing Outer Membrane Vesicle (OMV) technology to the next level by decorating their surface with a palette of antigens at a high density. This adaptation of a natural system for bacterial protein secretion into the most efficient and versatile system for surface display of antigens known today is a notable innovation. Abera's platform allows for the development of efficient multivalent, multi-stage vaccines for oral and nasal administration, along with faster and more cost-effective production. Their OMV-based vaccines can be manufactured within 14-30 days, marking a significant advancement in vaccine production technology. Founded in 2012, Abera Bioscience AB is poised to make a substantial impact on the global health sector through their innovative approach to vaccine development and production.

Taxonomy: Vaccine Delivery Platform, Vaccine Development, Outer Membrane Vesicles (OMV), Biochemistry, Molecular Microbiology, Biotech Company, Multivalent Vaccines, Multi-Stage Vaccines, Oral Administration, Nasal Administration, Patented Platform Technology, Efficient Production, Cost-Effective Production, Swedish Biotech Company

No funding data available for Abera Bioscience AB yet.

Abera Bioscience AB Alternatives & Competitors

Abera Bioscience AB vs
VaxForm
VaxForm United States

VaxForm envisions a world where formulation takes a leading role in providing solutions to the devel...

Grant
6 employees
Biotechnology, Health Care
Abera Bioscience AB vs
Vaxcyte
Vaxcyte United States

Developing superior and novel vaccines designed to treat some of the most common and deadly infectio...

IPO
543 employees
Biopharma, Biotechnology

FAQ About Abera Bioscience AB

A vaccine plattform company
Abera Bioscience AB was founded in 2012.
Abera Bioscience AB is headquartered in Sweden.
Abera Bioscience AB operates in Biotechnology and Health Care. Its work centres on Vaccine Delivery Platform, Vaccine Development, Outer Membrane Vesicles (OMV) and Biochemistry.
Abera Bioscience AB has approximately 11 employees.
Top alternatives and competitors to Abera Bioscience AB include VaxForm, Vaxcyte. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Abera Bioscience AB and VaxForm are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Abera Bioscience AB, https://bouncewatch.com/company/abera-bioscience-ab, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes